Navigation Links
Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
Date:8/1/2011

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

http://www.reportlinker.com/p0581176/Dry-Powder-Inhalation-Devices-Drugs-Therapeutics-Markets-and-Forecasts .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalation (DPI) as a formidable challenger to more established pulmonary methods such as metered dose inhalers and nebulizers. While evolving DPI technology and combination therapeutic products continue to have a significant impact on the treatment of upper respiratory diseases and conditions, dry powder inhalers are making strides in applications requiring the systemic delivery of both small and large molecule and engineered macromolecules for the treatment of a range of pathologies.

Highlights

• Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products

• Examines Dry Powder Inhaler design issues and evolving market factors

• Forecasts the impact of DPI technology and devices on drug delivery markets and projects probable future developments

• Provides forecasts of DPI combination product demand by indication and drug class to 2014

• Profiles Dry Powder Inhalation market participants, their technology, product development activity, and business strategies

Executive Summary

The Market Picture for Inhaled Therapeutics

Devices, Formulations and Market Evolution

Established Therapeutic Targets

Emerging Therapies

Demographics and Growth

Competing Technologies

Market Drivers

Risk Factors

Dry Powder Inhalation Technology

Dry Powder Formulations

Dry Powder Particle Technology & Powder Engineering

Dry Powder Formulations

Dry Powder Processing

Dry Powder Packaging

Emerging Formulations

Dry Powder Inhalers

DPI Device Characteristics

DPI Design Parameters

DPI Device Assessments

Acu-Breathe (Respirics)

Aerolizer Novartis)

AIR (Civitas/Alkermes)

Airmax (Teva)

Aspirair (Vectura)

Axahaler (S.M.B.)

Breezhaler (Novartis)

Clickhaler (Vectura)

Conix Dry (3M)

Cricket (Mannkind)

Cyclohaler (Teva)

Diskhaler (GlaxoSmithKline)

Diskus (GlaxoSmithKline)

Dreamboat (Mannkind)

Easyhaler (Orion)

EZ Aer (Aerovance)

Flexhaler (AstraZeneca)

Genuair (Almirall)

Gemini (GSK)

Handihaler Boehringer Ingelheim)

MicroDose (MicroDose Therapeutx)

Next DPI (Chiesi)

Novolizer (Meda)

Oximax (Mantecorp)

Podhaler (Novartis)

Pulmojet (sanofi-aventis)

Pulvinal (Chiesi)

Skyehaler (SKyepharma)

Solis (Sandoz/Novartis)

Taifun (Akela)

Taper Dry (3M)

Trivair (Trimel Bipharma)

Twincaps/Flowcaps (Hovione)

Twisthaler (Schering /Merck)

Turbuhaler (AstraZeneca)

Dry Powder Inhalation – Therapeutic Segment Analysis & Forecasts

Upper Respiratory Indications

Disease Segments

Therapeutic Landscape

Prescribing Trends and Growth Factors

Systemic Drug Delivery

Bioterror

Diabetes

Hereditary Diseases

Cystic Fibrosis

Infectious Diseases

Osteoporosis

Neurology

Pain Management

Market Factors

Device Design

Regulatory Issues

Patient Compliance

The Role of CMOs/CSOs

Healthcare Economics

Company Profiles

To order this report:

Drug Delivery Technology Industry: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

Drug Delivery Technology Business News

More  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
3. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
4. New Powder Speeds Healing of Difficult Foot Wounds
5. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
6. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
7. Hoviones TwinCaps(R) Dry-powder Inhaler Approved in Japan as Part of Inavir(R) Influenza Treatment
8. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Reportlinker Adds Dry Powder Inhalation
10. Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
11. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 24, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the Cowen and Company 37 ... Marriott Copley Place on Tuesday, March 7, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/24/2017)... , Feb. 24, 2017  In conjunction with ... 2016 financial results press release, you are invited to ... live over the internet on Tuesday, March 14, 2017 ... A live audio webcast of the presentation ... www.durect.com and clicking "Investor Relations."  If you are ...
(Date:2/24/2017)... 24. Februar 2017 ITL Limited, ( ... Gesundheitsbereiches, ist erfreut, für das zum 31. Dezember ... Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine vollständige ... Wachstum" finden Sie hier . ... Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... , ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently ... as the Chairman of the Management Committee when IFN was originally formed in 2002 ... of investor/owners and development of the business plan. He became the first paid ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
Breaking Medicine News(10 mins):